ATE417823T1 - Verbindungen auf lysinbasis - Google Patents

Verbindungen auf lysinbasis

Info

Publication number
ATE417823T1
ATE417823T1 AT04761606T AT04761606T ATE417823T1 AT E417823 T1 ATE417823 T1 AT E417823T1 AT 04761606 T AT04761606 T AT 04761606T AT 04761606 T AT04761606 T AT 04761606T AT E417823 T1 ATE417823 T1 AT E417823T1
Authority
AT
Austria
Prior art keywords
lysine
based compounds
cycloalkyl
alkyl
nao
Prior art date
Application number
AT04761606T
Other languages
English (en)
Inventor
Brent Stranix
Valerie Perron
Original Assignee
Ambrilia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrilia Biopharma Inc filed Critical Ambrilia Biopharma Inc
Application granted granted Critical
Publication of ATE417823T1 publication Critical patent/ATE417823T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT04761606T 2004-08-02 2004-08-02 Verbindungen auf lysinbasis ATE417823T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2004/001440 WO2006012725A1 (en) 2004-08-02 2004-08-02 Lysine based compounds

Publications (1)

Publication Number Publication Date
ATE417823T1 true ATE417823T1 (de) 2009-01-15

Family

ID=35786842

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761606T ATE417823T1 (de) 2004-08-02 2004-08-02 Verbindungen auf lysinbasis

Country Status (14)

Country Link
EP (2) EP2165709B1 (de)
JP (1) JP4579970B2 (de)
CN (1) CN1942436B (de)
AT (1) ATE417823T1 (de)
AU (2) AU2004322123B2 (de)
BR (1) BRPI0418651A (de)
CA (1) CA2560071C (de)
DE (1) DE602004018548D1 (de)
ES (2) ES2319996T3 (de)
IL (1) IL180958A0 (de)
MX (1) MX2007001278A (de)
NO (1) NO20071152L (de)
RU (1) RU2009139259A (de)
WO (1) WO2006012725A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
EP2165709B1 (de) 2004-08-02 2016-03-16 Ambrilia Biopharma Inc. Pharmazeutische Zusammensetzungen enthaltend eine Lysin-basierende Verbindung und ein HIV-antivirales order antiretrovirales Agens
WO2007062526A1 (en) 2005-11-30 2007-06-07 Ambrilia Biopharma Inc. Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation
AU2007287353A1 (en) * 2006-07-17 2008-02-28 Ambrilia Biopharma Inc. Method for improving pharmacokinetics
ES2628730T3 (es) 2006-09-21 2017-08-03 Taimed Biologics, Inc. Inhibidores de proteasa
WO2009148600A2 (en) * 2008-06-06 2009-12-10 Concert Pharmaceuticals, Inc. Deuterated lysine-based compounds
CA2762582A1 (en) 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. Hiv protease inhibitors
US9079834B2 (en) 2010-10-28 2015-07-14 Merck Canada Inc. HIV protease inhibitors
US9187415B2 (en) 2010-10-29 2015-11-17 Merck Canada Inc. Sulfonamides as HIV protease inhibitors
US9133157B2 (en) 2011-10-26 2015-09-15 Merck Canada Inc. HIV protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
WO2001076531A2 (en) * 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
CA2418479C (en) * 2000-08-18 2007-12-18 The Board Of Trustees Of The University Of Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US6632816B1 (en) * 2002-12-23 2003-10-14 Pharmacor Inc. Aromatic derivatives as HIV aspartyl protease inhibitors
EP2165709B1 (de) 2004-08-02 2016-03-16 Ambrilia Biopharma Inc. Pharmazeutische Zusammensetzungen enthaltend eine Lysin-basierende Verbindung und ein HIV-antivirales order antiretrovirales Agens

Also Published As

Publication number Publication date
DE602004018548D1 (de) 2009-01-29
RU2009139259A (ru) 2011-04-27
EP2165709A2 (de) 2010-03-24
NO20071152L (no) 2007-03-01
EP2165709B1 (de) 2016-03-16
HK1105406A1 (en) 2008-02-15
AU2009230800A1 (en) 2009-11-19
JP2007525527A (ja) 2007-09-06
CN1942436A (zh) 2007-04-04
CA2560071A1 (en) 2006-02-09
EP1773763B1 (de) 2008-12-17
MX2007001278A (es) 2007-09-14
EP1773763A1 (de) 2007-04-18
ES2319996T3 (es) 2009-05-18
AU2004322123B2 (en) 2009-08-13
ES2575871T3 (es) 2016-07-01
AU2004322123A1 (en) 2006-02-09
JP4579970B2 (ja) 2010-11-10
BRPI0418651A (pt) 2007-05-29
CN1942436B (zh) 2011-03-23
EP2165709A3 (de) 2010-06-23
EP1773763A4 (de) 2007-08-08
IL180958A0 (en) 2007-07-04
CA2560071C (en) 2012-09-25
WO2006012725A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
NO20071152L (no) Lysinbaserte forbindelser
ATE425983T1 (de) Siloxy substituierte metallocenkatalysatoren
EP1795536A4 (de) Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna
EA200970478A1 (ru) Аналоги тиофена для лечения или предупреждения флавивирусных инфекций
DE60227794D1 (de) Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon
DE60236859D1 (de) Verbindung geeignet für den einsatz in organischen elektrolumineszenselementen und organische elektrolumineszenselemente
DE60212867D1 (de) Thiazolylsubstituierte aminopyrimidine als pflanzenschutzmittel
BR0313943A (pt) Composto benzanilida substituìdo e agente de controle de organismo nocivo
DE60239884D1 (de) Pyrimidinverbindung und diese enthaltende medizinische zusammensetzung
DE60215656D1 (de) Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
MY145159A (en) Stabiliser composition for chlorine-containing polymers
BR0111780A (pt) Agente herbicida
ATE543515T1 (de) Konjugate von hydroxyalkyl-stärke und einer wirksubstanz, hergestellt durch chemische ligation über thiazolidin
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
DK2000473T3 (da) Trehalose-forbindelse og lægemiddel omfattende forbindelsen
DE60223904D1 (de) Benzylaminanalogen
ATE526323T1 (de) Die hiv-protease hemmende verbindungen
BR0117191A (pt) Composições nanoparticuladas de isotretinoina
CL2004000160A1 (es) Derivados de avermectina sustituidos en posicion 4' y 4'', composicion que los contiene, utiles como plaguicidas.
ATE517087T1 (de) Cbp-verbindung
ATE444968T1 (de) Neuroprotektive verbindungen und deren verwendungen
DE602006012361D1 (de) Schmutzlösungsmittel
EP2045258A4 (de) 3ý-ETHYNYLCYTIDINDERIVAT
DK0787710T3 (da) Fluorpropenforbindelse, et insekticid indeholdende samme og et mellemprodukt til fremstilling deraf

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties